In the presence of amyloid pathology, there was a significant increase of SHIP2-immunoreactivity observed around amyloid plaques in AD brains and in 5xFAD transgenic mouse brains bearing amyloid pathology [67]. This evidence concerns the gene INPPL1 and Alzheimer disease.